## Abstract ## BACKGROUND. Estimates of prostate cancer‐specific mortality (PCSM) were determined after radical prostatectomy (RP) or radiation therapy (RT) in men with ≥1 high‐risk factors. ## METHODS. The study cohort comprised 948 men who underwent RP (N = 660) or RT (N = 288) for localized p
Differences in cause-specific mortality in patients with low-and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
✍ Scribed by Jay P. Ciezki; Chandana A. Reddy; Clifford Robinson; Eric A. Klein; Kenneth Angermeier; James Ulchaker; Andrew Altman; Nabil Chehade
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 49 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1538-4721
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancer‐specific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with short‐course androgen suppression therapy (RT+AST) or radica
## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative long‐term efficacy of radical prostatectomy (RP) versus conventional‐dose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A